AAJT-S Junctional Tourniquet Appears on ABC’s The Rookie Feds

The team at Compression Works was pleased to see the AAJT-S junctional tourniquet used on the popular ABC television show The Rookie Feds on Saturday, November 26th.  During the episode, a medic treating a patient with a gunshot wound in the abdomen applied the AAJT-S, and explained that the device would stay in place for up to an hour to stop the victim’s bleeding. While this is of course a dramatization, we’re thrilled the producers of Rookie Feds used the AAJT-S in the scene.

It’s not surprising to see the use of our device portrayed in a show like this, as the AAJT-S is the only junctional tourniquet proven to save human life in upper and lower non-compressible bleeding.  Used successfully in both military combat and civilian pre-hospital and emergency settings, the AAJT-S is FDA-cleared to control difficult bleeding situations in the abdomen, axilla, inguinal area, and pelvic fractures.

Learn more about how the AAJT-S is saving lives in the field.

 

Compression Works Announces Scott Garrett as Chief Operating Officer

Compression Works Inc., the medical device company that created the Abdominal Aortic and Junctional Tourniquet – Stabilized (AAJT-S) for the treatment of non-compressible hemorrhages in the global EMS and military markets, welcomes Scott Garrett as its new Chief Operating Officer. In his new role, Mr. Garrett will be responsible for driving company growth, scaling operations to meet the increasing global demand for the AAJT-S device and increasing sales in the global EMS, first responder, tactical law enforcement and military markets. 

“We are absolutely thrilled to have Scott Garrett join our executive team,” stated President and CEO of Compression Works, Scott Dodson. “Scott is a recognized leader and expert with a proven track record in both the EMS and military verticals where our life-saving device is used,” said Dodson. “His impact will be felt immediately as we accelerate the commercialization and distribution of our technology around the world.” 

Prior to joining Compression Works, Scott Garrett was the Vice President of Sales for the Military/Tactical/Distribution and Urology Division within the Anesthesiology and Emergency Medicine business unit at Teleflex, a multi-billion-dollar global medical device company.  Scott also served as the Global Vice President for Military/Tactical Programs at Z-Medica which was acquired by Teleflex.  Mr. Garrett has over 16 years of increasing levels of responsibility in the trauma, military, pre-hospital, tactical, law enforcement, international military business management and market development segments for medical devices. 

Scott also served for 8 years in the U.S. Army as a Combat Arms Officer and achieved the rank of Captain with multiple deployments, including Iraq and Bosnia. He graduated from Texas A&M University as a Distinguished Military Graduate, with a Bachelor of Science degree in political science and an MBA from University of Texas-Arlington.

 “I am looking forward to being a part of the Compression Works team that brings the AAJT-S to markets around the world where it will have an immediate impact in saving lives,” said Scott Garrett. “I have always been attracted to technologies that make a difference, and in trauma situations there is no greater factor in a patient’s survival than stopping blood loss. The Compression Works technology stops the most difficult bleeding conditions so the patient can be stabilized and taken to definitive care,” said Garrett.

The AAJT-S by Compression Works is made in the United States of America and has thousands of devices in use in markets around the world. For more information, visit or contact us at www.compressionworks.com. 

About Compression Works

Compression Works is the developer and manufacturer of the Abdominal Aortic and Junctional Tourniquet – Stabilized (AAJT-S) medical device. The company delivers innovative solutions to meet the most pressing and unmet needs of emergency healthcare providers. Compression Works is committed to hemorrhage control research, identifying capability gaps and developing technologies and products to help facilitate the delivery of quality life-saving care. The solution is used by the military, trauma centers, rural emergency departments, EMS and federal and local law enforcement agencies. The AAJT-S device is proudly manufactured and assembled in the USA. Compression Works is a veteran-owned business dedicated to saving lives on and off the battlefield. 

Medical Device Startup Raising $2M for ‘Swiss Army Knife’ of Tourniquets

By: Kevin Cummings, Dallas Innovates • MAY 2022

Compression Works, a medical device company founded by two military veterans, developed its innovative conical-bladder tourniquet for use by U.S. special forces in Iraq and Afghanistan back in 2008. Now it’s expanding the device’s use for EMS teams and fire departments in Dallas and other large U.S. cities, and raising $2 million to help fuel the company’s growth.

A Dallas CEO is taking tech made for the battlefield to help first responders save lives on the home front. “Necessity is the mother of invention, and this is what really spurred the initial activity for our technology,” Dodson told Dallas Innovates. “The tourniquet was really developed out of necessity on the battlefields of Iraq and Afghanistan—a technology that would stop the most significant bleeds at the point of injury and allow them to stabilize the patient and get them to a point of definitive care.”

Stopping the bleeding
Unlike traditional tourniquets, which Dodson said work for superficial wounds and those on extremities, Compression Works’ device—called the abdominal and aortic junctional tourniquet-stabilized (AAJT-S)—can be used to stop bleeding on areas like the shoulder, abdomen, and pelvis.
The device can be easily carried by first responders for use in the field. In a five-step process, they position the device, fasten it to a patient, and inflate a conical bladder that inserts itself in the body to stop hemorrhaging. 

Dodson said his company is also exploring potential uses to help stabilize heart attack victims en route to the hospital and to stop postpartum hemorrhage, which he noted is a leading cause of maternal deaths outside the U.S.

“The genius behind our device is that it is also a belt type system that wraps around the patient in five different parts of their anatomy,” Dodson said. “When you put pressure into this bladder, it literally inflates in this cone shape into the body, pressing against the vessels and shutting off the bleeding like turning off a faucet.”

Battlefield origins
Compression Works was co-founded in 2008 by Dr. John Croushorn and Dr. Richard Schwartz so the device could be used by military special forces on the field. Both cofounders are veterans, and they received FDA approval for the device within eight days. At that time, the device was picked up by special operations forces like the Navy SEALs and Army Rangers.

Dodson says that until about two years ago, the company was largely run as a passion project. Then the decision was made to scale the business in an effort led by Dodson, who has experience at large tech firms and numerous venture-backed startups. While the company has historically been based in Alabama, Dodson is based in Dallas and says his company plans to continue its growth from the North Texas region.

“We’ve really been pivoting the company over the last two years, standing up distribution, not only coast to coast in the United States to call on a significant opportunity in the EMS and tactical law enforcement markets, but also in international markets around the world,” Dodson said.

Compression Works seeks to raise $2 million
Since the decision to scale, rather than sell off assets or spin off the technology, Compression Works has expanded its presence and is now used in 18 countries and is adding about five to six new countries per quarter, Dodson said. The company currently works with five regional distributors across the U.S., all focused on the first responder space. The device is currently being used by a number of large fire departments and EMS organizations, including in Dallas, New York City, and the Miami-Dade area.

To help continue its growth trajectory, Compression Works is in the middle of raising a $2 million convertible note, of which Dodson said it has closed about 75%. With the new funding, the company will be bringing on new team members to expand its production capabilities and find new clients in the field.
“We think that the momentum will continue to build on this, given the applicability of this device and the fact that it’s so small and compact,” Dodson said. “It can really drop on to any vehicle or into any medic or paramedic’s go-pack and go along with him to the accident site.”

This article, “Medical Device Startup Raising $2M for ‘Swiss Army Knife’ of Tourniquets” was originally featured on Dallas Innovates on May 18, 2022. A collaboration of the Dallas Regional Chamber and Dallas Next, Dallas Innovates is an online news platform covering what’s new + next in Dallas – Fort Worth innovation.

Comprehensive Scientific Study Demonstrates Compression Works AAJT-S Device Useful in Traumatic Cardiac Arrest and Non-Compressible Truncal Hemorrhage Patients

BIRMINGHAM, AL – May 3, 2022 – Compression Works, creators of the Abdominal Aortic and Junctional Tourniquet – Stabilized (AAJT-S) device, announces the publication of a new trauma review article in the Annals of Emergency Medicine, “External Aortic Compression in Noncompressible Truncal Hemorrhage and Traumatic Cardiac Arrest: A Scoping Review.” The study examines aortic compression as it relates to non-compressible truncal hemorrhage and traumatic cardiac arrest subjects.

The Annals of Emergency Medicine study used a meta-analysis format to assess thousands of case-series and peer-reviewed publications and found that the evidence supports the finding that external aortic compression achieves the cesassation of distal blood flow and may improve the physiological parameters in the setting of hypovolemic shock. “The study looked at both manual methods of placing a knee or fist into the abdomen to exert force to achieve aortic compression and it looked at the use of the AAJT-S device to achieve this effect. The AAJT-S device was created to do just this, given that manual compression cannot be maintained easily when trying to move a patient,” said Chief Medical Officer of Compression Works, Inc. Dr. John Croushorn. 

The AAJT-S device by Compression Works is currently FDA cleared to treat non-compressible hemorrhages in the axilla, abdomen and groin region.  The AAJT-S can also stabilize pelvic fractures and has been shown in multiple independent peer-reviewed publications to be equivalent to Zone-3 REBOA. The multi-functional device is currently being used by EMS first responders, the U.S military, allies and in the Ukrainian military in the current conflict in Ukraine to stabilize patients and casualties until they can reach definitive care. 

“We are thrilled with the confirmation in this recent publication and know the Compression Works device can play a major role in the treatment of difficult and often fatal injuries,”  said Dr. John Croushorn.  “As the AAJT-S device is the only device cleared for use on the abdomen as a truncal tourniquet, the physiological benefits of stopping blood flow to the distal extremities is already well established through the data from Zone-3 REBOA (Resuscitative Endovascular Balloon Occlusion of the Aorta).”

“The Compression Works device has been used effectively and safely to provide external aortic compression. It is completely non-invasive and can be applied at the point of injury by a first responder or medic making it a practical and cost effective solution,” stated Croushorn. “The device can help deliver more stable patients to awaiting trauma teams where they can then decide the best course of action,” further stated Dr. Croushorn.    

“With over 70 scientific studies published about the Compression Works’ life-saving device, the AAJT-S is the most studied device in its class. This latest publication further validates the current uses of the AAJT-S to treat non-compressible truncal hemorrhage as well as potentially impacting a large number of patients who suffer traumatic or sudden cardiac arrest,” said President and CEO of Compession Works Scott Dodson.

Current products and techniques to treat critical bleeding injuries in the field remain limited and the AAJT-S device has demonstrated life saving capabilities in both civilian and military trauma situations. Junctional tourniquets have been on the market for over 10 years and the AAJT-S is the only device to have documented lives saved in upper and lower junctional bleeding

The AAJT-S by Compression Works is made in the United States of America and has thousands of devices in the global market with U.S. special operations forces, allied special operations units and in the pre-hospital EMS segment in the United States and around the world. For more information, visit or contact us at www.compressionworks.com. 

About Compression Works

Compression Works is the developer and manufacturer of the Abdominal Aortic and Junctional Tourniquet – Stabilized (AAJT-S) medical device. The company delivers innovative solutions to meet the most pressing and unmet needs of emergency healthcare providers. Compression Works is committed to hemorrhage control research, identifying capability gaps and developing technologies and products to help facilitate the delivery of quality life-saving care. The solution is used by the military, trauma centers, rural emergency departments, EMS and federal and local law enforcement agencies. The AAJT-S device is proudly manufactured and assembled in the USA. Compression Works is a veteran-owned business dedicated to saving lives on and off the battlefield. 



Compression Works Rushing Unique Life-Saving Tourniquets to Ukraine

BIRMINGHAM, AL – April 4, 2022 – Compression Works, Inc. maker of the Abdominal Aortic and Junctional Tourniquet – Stabilized (AAJT-S) device, announces a relief effort to support the people of Ukraine with its life-saving hemorrhage control solution. The AAJT-S devices are intended to help warfighters and civilians who have been injured as a result of the Russia invasion.

“We were honored to have met Mr. Ivan Danchak, a Ukranian native who immigrated to the United States in 2004. After joining the U.S. military as an infantryman, he deployed to Al-Asad Iraq with the 3rd Infantry Division in 2010 – 2011. Like so many ex-patriate citizens, Mr. Danchak has family and friends still in Ukraine who are fighting for their freedom, homes and country following the invasion,” said President and CEO of Compression Works, Inc. Scott Dodson.  “Mr. Danchak has been raising relief funds in the United States to purchase medical equipment for the war effort and we were humbled to have the opportunity to provide his group with devices to send to the region to help save lives,” said Dodson.

The Compression Works device is designed to stop traumatic bleeding resulting from non-compressible hemorrhages.  The AAJT-S is being used by the U.S. military, U.S. special operations forces, allied special operations units and in the pre-hospital EMS segment around the world to stop non-compressible hemorrhages and save lives. “The U.S. Department of Defense estimates that more than 20% of injured soldiers can be saved if the bleeding that they endure at the point of injury can be stopped so that they can be stabilized and transported to definitive care. This also translates to civilians that are injured in conflicts and for traumatic pre-hospital injuries as well,” added Dodson.

“The AAJT-S can be used to stop bleeding in the upper and lower extremities, and is the only device FDA cleared for use on the abdomen.  The device can also be used to stabilize pelvic fractures, has been studied to demonstrate equivalence to Zone 3 REBOA and is completely non-invasive, making it the most multi-functional, life-saving tourniquet available today.  The device has documented lives saved for both upper and lower applications and has more than 70 peer-reviewed publications demonstrating its safety and effectiveness,” said co-inventor and Chief Medical Officer of Compression Works Dr. John Croushorn.

“As a newer citizen of the United States, my allegiance is to this country. My heart, passion and resources are being directed to Ukraine as my home country fights the tyranny of an invading army that is threatening democracy and the very lives of my family and friends still there,” said Ivan Danchak.  “I am grateful for the support of Compression Works to help the freedom fighters and citizens of Ukraine who are being injured in this struggle,” continued Danchak.

“We are diligently working to help support this effort to get the devices in the hands of those who can save the lives of those on the front lines and caught in the cross-fire of this conflict,” said Dodson.  “We encourage everyone to get involved to help the besieged country of Ukraine and its citizens who are fighting to preserve their country and the lives of those that they love.”

To learn more about Mr. Ivan Danchak’s relief efforts or to contribute, contact him at ksmdanchak@gmail.com or visit  The Ukraine Go Fund Me Page.

About Compression Works

Compression Works is the developer and manufacturer of the Abdominal Aortic and Junctional Tourniquet – Stabilized (AAJT-S) medical device. The company delivers innovative solutions to meet the most pressing and unmet needs of emergency healthcare providers and military medical caregivers.

Compression Works is committed to hemorrhage control research, identifying capability gaps and developing technologies and products to help facilitate the delivery of quality life-saving care. The life-saving multi-use technology is used by the U.S. military, trauma centers, rural emergency departments, EMS and federal and local law enforcement agencies. The AAJT-S device is proudly manufactured and assembled in the USA. Compression Works is a veteran owned business dedicated to saving lives on and off the battlefield. 

Posts navigation